Cotempla XR-ODT (Neos Therapeutics, LP)
Welcome to the PulseAid listing for the Cotempla XR-ODT drug offered from Neos Therapeutics, LP. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Neos Therapeutics, LP |
NON-PROPRIETARY NAME: | Methylphenidate |
SUBSTANCE NAME: | METHYLPHENIDATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, ORALLY DISINTEGRATING |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-06-20 |
END MARKETING DATE: | 0000-00-00 |
Cotempla XR-ODT HUMAN PRESCRIPTION DRUG Details:
Item Description | Cotempla XR-ODT from Neos Therapeutics, LP |
LABELER NAME: | Neos Therapeutics, LP |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 8.6(mg/1) |
START MARKETING DATE: | 2016-06-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70165-100_8dfc75eb-b2cc-4187-8205-76f0e9a52a8b |
PRODUCT NDC: | 70165-100 |
APPLICATION NUMBER: | NDA205489 |
Other METHYLPHENIDATE Pharmaceutical Manufacturers / Labelers: